Pcv (Pneumococcal Conjugate Vaccine) Suppliers & Bulk Manufacturers
Available Forms: Vial doses, Pre-filled syringes
Available Strengths: 0.5 mL
Reference Brands: Prevnar 13(US)
Category:
Vaccines
PCV (Pneumococcal Conjugate Vaccine) stimulates immunity by introducing polysaccharides linked to proteins, prompting the body to produce antibodies against pneumococcal bacteria. It prevents pneumonia, meningitis, and bacteremia, reducing illness, hospitalizations, and death, especially in children, supporting lifelong protection and community health.
PCV (Pneumococcal Conjugate Vaccine) is available in Vial doses, Pre-filled syringes
and strengths such as 0.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, PCV (Pneumococcal Conjugate Vaccine) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
PCV (Pneumococcal Conjugate Vaccine) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
PCV (Pneumococcal Conjugate Vaccine) is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval requires comprehensive clinical data; in the EU, CE marking certifies conformity with in vitro diagnostic and medicinal regulations. These vaccines undergo validation, stability testing, and extensive audits, with detailed documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective pneumococcal vaccines for global immunization efforts reducing pneumonia, meningitis, and sepsis.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing